Evidence map›Paper›PMID 37769008›Full record

ArticlePLoS neglected tropical diseases2023

Epidemiological and genomic investigation of chikungunya virus in Rio de Janeiro state, Brazil, between 2015 and 2018.

Filipe Romero Rebello Moreira, Mariane Talon de Menezes, Clarisse Salgado-Benvindo, Charles Whittaker, Victoria Cox, Nilani Chandradeva, Hury Hellen Souza de Paula, André Frederico Martins, Raphael Rangel das Chagas, Rodrigo Decembrino Vargas Brasil and 15 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Revisiting the emergence of the Chikungunya virus in Alagoas, Northeast of Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  3. Unique signatures of airway and systemic immunity in severe COVID-19 patients infected with alpha to Omicron SARS-CoV-2 variants of concern.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  4. IL-17 as a putative hallmark of intense arthralgia and age-related serum immune mediator networks during acute chikungunya fever.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  5. Article
  6. High Frequencies ofPathogens (Basel, Switzerland) · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 4 countries.

Filipe Romero Rebello MoreiraDepartamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0002-7162-5070
Mariane Talon de MenezesDepartamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Clarisse Salgado-BenvindoDepartamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Charles WhittakerMRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, United Kingdom.
Victoria CoxMRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, United Kingdom.
Nilani ChandradevaMRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, United Kingdom.
Hury Hellen Souza de PaulaDepartamento de Saúde, Programa de Pós-graduação em Biomedicina Translacional, Universidade do Grande Rio (UNIGRANRIO), Duque de Caxias, Rio de Janeiro, Brazil.
André Frederico MartinsDepartamento de Saúde, Programa de Pós-graduação em Biomedicina Translacional, Universidade do Grande Rio (UNIGRANRIO), Duque de Caxias, Rio de Janeiro, Brazil.
Raphael Rangel das ChagasDepartamento de Saúde, Programa de Pós-graduação em Biomedicina Translacional, Universidade do Grande Rio (UNIGRANRIO), Duque de Caxias, Rio de Janeiro, Brazil.
Rodrigo Decembrino Vargas BrasilDepartamento de Saúde, Programa de Pós-graduação em Biomedicina Translacional, Universidade do Grande Rio (UNIGRANRIO), Duque de Caxias, Rio de Janeiro, Brazil.
Darlan da Silva CândidoMRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, United Kingdom.
Alice Laschuk HerlingerDepartamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Marisa de Oliveira RibeiroInstitute of Technology in Immunobiology Bio-Manguinhos, Oswaldo Cruz Foundation/ Fiocruz, Rio de Janeiro, Brazil.
Monica Barcellos ArrudaInstitute of Technology in Immunobiology Bio-Manguinhos, Oswaldo Cruz Foundation/ Fiocruz, Rio de Janeiro, Brazil.
Patricia AlvarezInstitute of Technology in Immunobiology Bio-Manguinhos, Oswaldo Cruz Foundation/ Fiocruz, Rio de Janeiro, Brazil.
Marcelo Calado de Paula TôrresDepartamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Ilaria DorigattiMRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, United Kingdom.
Oliver BradyCentre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Carolina Moreira VolochDepartamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Amilcar TanuriDepartamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Felipe IaniFundação Ezequiel Dias (FUNED), Belo Horizonte, Minas Gerais, Brazil.
William Marciel de SouzaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Sergian Vianna CardozoDepartamento de Saúde, Programa de Pós-graduação em Biomedicina Translacional, Universidade do Grande Rio (UNIGRANRIO), Duque de Caxias, Rio de Janeiro, Brazil.
Nuno Rodrigues FariaMRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, United Kingdom.
Renato Santana AguiarDepartamento de Genética, Ecologia e Evolução, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0001-5180-3717
Universidade Federal do Rio de Janeiro · BRUniversidade Unigranrio · BRImperial College London · GBFundação Oswaldo Cruz · BREzequiel Dias Foundation · BRLondon School of Hygiene & Tropical Medicine · GBThe University of Texas Medical Branch at Galveston · USUniversidade de São Paulo · BRUniversidade Federal de Minas Gerais · BRUniversity of Oxford · GB

Funding

Medical Research Council MR/R015600/1Medical Research Council MR/S019510/1Medical Research Council MR/V031112/1Wellcome Trust
6 · The paper itself

Abstract

Since 2014, Brazil has experienced an unprecedented epidemic caused by chikungunya virus (CHIKV), with several waves of East-Central-South-African (ECSA) lineage transmission reported across the country. In 2018, Rio de Janeiro state, the third most populous state in Brazil, reported 41% of all chikungunya cases in the country. Here we use evolutionary and epidemiological analysis to estimate the timescale of CHIKV-ECSA-American lineage and its epidemiological patterns in Rio de Janeiro. We show that the CHIKV-ECSA outbreak in Rio de Janeiro derived from two distinct clades introduced from the Northeast region in mid-2015 (clade RJ1, n = 63/67 genomes from Rio de Janeiro) and mid-2017 (clade RJ2, n = 4/67). We detected evidence for positive selection in non-structural proteins linked with viral replication in the RJ1 clade (clade-defining: nsP4-A481D) and the RJ2 clade (nsP1-D531G). Finally, we estimate the CHIKV-ECSA's basic reproduction number (R0) to be between 1.2 to 1.6 and show that its instantaneous reproduction number (Rt) displays a strong seasonal pattern with peaks in transmission coinciding with periods of high Aedes aegypti transmission potential. Our results highlight the need for continued genomic and epidemiological surveillance of CHIKV in Brazil, particularly during periods of high ecological suitability, and show that selective pressures underline the emergence and evolution of the large urban CHIKV-ECSA outbreak in Rio de Janeiro.

Indexed as

Chikungunya FeverChikungunya virusBrazilDisease OutbreaksGenomicsHumansPhylogeny

Identifiers

PMID37769008
PMCPMC10564160
OpenAlexW4387141712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.